000			01167 a2200313 4500
005			20250518055759.0
264		0	_c20210527
008			202105s 0 0 eng d
022			_a1873-7560
024	7		_a10.1016/j.eururo.2019.08.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aGorchakov, Andrey A
245	0	0	_aChallenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer. _h[electronic resource]
260			_bEuropean urology _c03 2020
300			_a299-308 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aCell- and Tissue-Based Therapy _xmethods
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aNeoplasm Metastasis
650	0	4	_aProstatic Neoplasms _ximmunology
650	0	4	_aReceptors, Chimeric Antigen _ximmunology
650	0	4	_aT-Lymphocytes _ximmunology
700	1		_aKulemzin, Sergey V
700	1		_aKochneva, Galina V
700	1		_aTaranin, Aleksandr V
773	0		_tEuropean urology _gvol. 77 _gno. 3 _gp. 299-308
856	4	0	_uhttps://doi.org/10.1016/j.eururo.2019.08.014 _zAvailable from publisher's website
999			_c30062959 _d30062959